Opioid Endocrinopathy in Women Consuming Prescribed Sustained-Action Opioids for Control of Nonmalignant Pain

Journal of Pain

Volumn 9, Issue 1, 2008, Pages 28-36

  Daniell, Harry W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

amenorrhea; DHEAS; estradiol; gonadotrophins; Hypogonadism; opioids; pain drug therapy; testosterone

Indexed keywords

ANDROGEN; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; OPIATE; PRASTERONE SULFATE; SEX HORMONE; TESTOSTERONE;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ANDROGEN SYNTHESIS; ARTICLE; BODY MASS; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENDOCRINE DISEASE; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; FEMALE FERTILITY; GONADOTROPIN BLOOD LEVEL; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; MENSTRUATION; OVARIECTOMY; PAIN; POSTMENOPAUSE; PREMENOPAUSE; SUSTAINED DRUG RELEASE;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADRENAL CORTEX; ADRENAL CORTEX DISEASES; ADULT; AGED; ANALGESICS, OPIOID; ANDROGENS; DELAYED-ACTION PREPARATIONS; DOWN-REGULATION; ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; GONADOTROPINS; HUMANS; HYPOGONADISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MIDDLE AGED; OVARY; PAIN;

EID: 37349031455     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2007.08.005     Document Type: Article

References (54)

1. Abs R., Verhelst J., Maeyaert J., Van Buyten J.P., Opsomer F., Adriaensen H., Verlooy J., Van Havenbergh T., Smet M., and Van Acker K. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 85 (2000) 2215-2222
2. Afrasiabi M.A., Flomm M., Friedlander H., and Valenta L. Endocrine studies in heroin addicts. Psychoneuroendocrinology 4 (1979) 145-153
3. Burger H.G. Androgen production in women. Fertil Steril 77 suppl 4 (2002) 3-5
4. Burger H.G., Dudley E.C., Cui J., Dennerstein L., and Hopper J.L. A prospective longitudinal study of serum testosterone dehydroepiandrosterone sulphate and sex hormone binding globulin levels through the menopause transition. J Clin Endocrinol Metab 85 (2000) 2832-2938
5. Cacicedo L., and Sanchez Franco F. Direct action of opioid peptides and naloxone on gonadotropin secretion by cultured rat anterior pituitary cells. Life Sci 38 (1986) 617-625
6. Cappola A., Ratcliffe S., Bhasin S., Blackman M., Cauley J., Robbins J., Zmuda J., Harris T., and Fried L. Determinants of serum total and free testosterone levels in women over the age of 65. J Clin Endocrin Metab 92 (2007) 509-516
7. Casson P.R., Elkind-Hirsch K.E., Bustser J.E., Hornsby P.J., Carson S.A., and Snabes M.C. Effect of postmenopausal estrogen replacement on circulating androgens. Obstet Gynecol 90 (1997) 995-998
8. Cofrancesco Jr. J., Shah N., Ghanem K., Dobs A., Klein R., Mayer K., Schuman P., Vlahov D., and Rompalo A. The effects of illicit drug use and HIV infection on sex hormone levels in women. Gynecol Endocrinol 22 (2006) 244-251
9. Couzinet B., Meduri G., Lecce M., Young J., Brailly S., Loosfelt H., Milgrom E., and Schaison G. The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metab 86 (2001) 5060-5066
10. Daniel M., Martin A., and Drinkwater D. Cigarette smoking, steroid hormones, and bone mineral density in young women. Calcif Tissue Int 50 (1992) 300-305
11. Daniell H.W. Hypogonadism in men consuming sustained-action oral opioids. J Pain 3 (2002) 377-384
12. Daniell H.W. DHEAS deficiency during consumption of sustained-action prescribed opioid-evidence for opioid-induced inhibition of adrenal androgen production. J Pain 7 (2006) 901-907
13. Daniell H.W., Lentz R., and Mazer N. Open-label study of testosterone patch therapy in men with opioid-induced androgen deficiency. J Pain 7 (2006) 200-210
14. Davison S.L., Bell R., Donath S., Montalto J.G., and Davis S.R. Androgen levels in adult females: Changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90 (2005) 3847-3853
15. Faletti A.G., Mastronardi C.A., Lomniczi A., Seilicovich A., Gimeno M., McCann S.M., and Rettori V. β-Endorphin blocks luteinizing hormone-releasing hormone release by inhibiting the nitricoxidergic pathway controlling its release. Proc Natl Acad Sci U S A 96 (1999) 1722-1726
16. Facchinetti F., Comitini G., Petraglia F., Volpe A., and Genazzani A.R. Reduced estriol and dehydroepiandrosterone sulphate plasma levels in methadone-addicted pregnant women. Eur J Obstet Gynecol Reprod Biol 23 (1986) 67-73
17. Facchinetti F., Volpe A., Farci G., Petraglia F., Porro C.A., Barbieri G., Cioni A., Balestrieri A., and Genazzani A.R. Hypothalamus-pituitary-adrenal axis of heroin addicts. Drug Alcohol Depend 15 (1985) 361-366
18. Finch P.M., Roberts L.J., Price L., Hadlow N.C., and Pullan P.T. Hypogonadism in patients treated with intrathecal morphine. Clin J Pain 16 (2000) 251-254
19. Forman L.J., Tingle V., Estilow S., and Carter J. The response to analgesia testing is affected by gonadal steroids in the rat. Life Sci 45 (1989) 447-454
20. Gower B., and Nyman L. Associations among oral estrogen use, free testosterone concentration, and lean body mass among postmenopausal women. J Clin Endocrinol Metab 85 (2000) 4476-4480
21. Hall G.M., Lacoumenta S., Hart G.R., and Burin J.M. Site of action of fentanyl in inhibiting the pituitary-adrenal response to surgery in man. Br J Anaesth 65 (1990) 251-253
22. Hemmings R., Fox G., and Tolis G. Effect of morphine on the hypothalamic-pituitary axis in postmenopausal women. Fertil Steril 37 (1982) 389-391
23. Ibanez L., Potau N., Marcos M.V., and de Zegher F. Corticotropin-releasing hormone: A potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche. J Clin Endocrinol Metab 84 (1999) 4602-4606
24. Kaminski T., Siawrys G., Bogacka I., Okrasa S., and Przala J. The regulation of steroidogenesis by opioid peptides in porcine theca cells. Anim Reprod Sci 78 (2003) 71-84
25. Khaw K.T., Chir M.B.B., Tazuke B.A., and Barrett-Connor E. Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med 318 (1988) 1705-1709
26. Khoromi S., Muniyappa R., Nackers L., Gray N., Baldwin H., Wong K.A., Matheny L.A., Moquin B., Rainer A., Hill S., Remaley A., Johnson L.L., Max M.B., and Blackman M.R. Effects of chronic osteoarthritis pain on neuroendocrine function in men. J Clin Endocrinol Metab 91 (2006) 4313-4318
27. Laughlin G., Barrett-Connor E., Kritz-Silverstein D., and von Mühlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo study. J Clin Endocrinol Metab 85 (2000) 645-651
28. Law M.R., Cheng R., Hackshaw A.K., Allaway S., and Hale A.K. Cigarette smoking, sex hormones and bone density in women. Eur J Epidemiol 13 (1997) 553-558
29. Mazer N. Testosterone deficiency in women: Etiologies, diagnosis, and emerging treatments. Int J Fertil 47 (2002) 77-86
30. McRae A., and Sonne S. Opioid equivalency: A review. J Pharm Pract 11 (1998) 394-404
31. Michna E., Ross E., Hynes W., Hynes W., Nedeljkovic S., Soumekh S., Janfaza D., Palombi D., and Jamison R. Predicting aberrant drug behavior in patients treated for chronic pain: Importance of abuse history. J Pain Symptom Manage 28 (2004) 250-258
32. Oltmanns K., Fehm H., and Peters A. Chronic fentanyl application induces adrenocortical insufficiency. J Intern Med 257 (2005) 478-480
33. Oncken C., Prestwood K., Cooney J.L., Unson C., Fall P., Kulldorff M., and Raisz L.G. Effects of smoking cessation or reduction on hormone profiles and bone turnover in postmenopausal women. Nicotine Tob Res 4 (2002) 451-458
34. Paice J.A., Penn R.D., and Ryan W.G. Altered sexual function and decreased testosterone in patients receiving intraspinal opioids. J Pain Sympton Manage 9 (1994) 126-131
35. Parker L.N., and Odell W.D. Evidence for existence of cortical androgen-stimulating hormone. Am J Physiol 236 (1979) E616-E620
36. Petraglia F., Porro C., Facchinetti F., Cicoli C., Bertellini E., Volpe A., Barbieri G.C., and Genazzani A.R. Opioid control of LH secretion in humans: Menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine. Life Sciences 38 (1986) 2103-2110
37. Raff H., Norton A., Flemma R., and Findling J. Inhibition of the adrenocorticotropin response to surgery in humans: Interaction between dexamethasone and fentanyl. J Clin Endocrinol Metab 65 (1987) 295
38. Rajagopal A., Vassilopoulou-Sellin R., Palmer J.L., Kaur G., and Bruera E. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer 100 (2004) 851-858
39. Rao C.V., Zhou X.L., and Lei Z.M. Functional luteinizing hormone/chorionic gonadotropin receptors in human adrenal cortical H295R cells. Biol Reprod 71 (2004) 579-587
40. Richter K.P., Gibson C.A., Ahluwalia J.S., and Schmeizie K.H. Tobacco use and quit attempts among methadone maintenance clients. Am J Public Health 91 (2001) 296-299
41. Sasaki A., Sato S., Murakami O., Go M., Inoue M., Shimizu Y., Hanew K., Andoh N., Sato I., and Sasano N. Immunoreactive corticotrophin-releasing hormone present in human plasma may be derived from both hypothalamic and extrahypothaloamic sources. J Clin Endocrinol Metab 65 (1987) 176-182
42. Schmittner J., Schroeder J.R., Epstein D.H., and Preston K.L. Menstrual cycle length during methadone maintenance. Addiction 100 (2005) 829-836
43. Shifren J.L., Braunstein G.D., Simon J.A., Casson P., Buster J., Redmond G., Burki R., Ginsburg E., Rosen R., Leiblum S., Caramelli K., and Mazer N. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343 (2000) 682-688
44. Shifren J., Desindes S., Stanworth S., McIlwain M., and Mazer N. A randomized, open label, cross-over study comparing the effects of transdermal vs oral estrogen therapy on free testosterone levels in naturally menopausal women. Endo (2004) P2-540
45. Simon J., Klaiber E., Wiita B., Bowen A., and Yang H.M. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women. Menopause 6 (1999) 138-146
46. Smith R., Mesiano S., Chan E.C., Brown S., and Jaffe R.B. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrinol Metab 83 (1998) 2916-2920
47. Sowers M., Beebe J., McConnell D., Randolph J., and Jannausch M. Testosterone concentrations in women aged 25-50 years: associations with lifestyle, body composition, and ovarian status. Am J Epidemiol 153 (2001) 256-264
48. Studd J.W.W., Collins W.P., and Chakravarti S. Plasma hormone profiles after the menopause and bilateral oophorectomy. Postgrad Med J 54 (1978) 25-30
49. Tennant F: Hypotestosteronemia and testosterone replacement in females with severe, persistent pain. 2005, Ann Mtg AM Pain Soc, Vancouver, BC P-767
50. Tinajero J.C., Perez J.U., Artola D., Alvarez J., and Lira S. Effect of opioid peptides on testosterone production in primary culture of Leydig cells (2000) Endo Society 82nd Annual Meeting Toronto;board 314 #1379
51. Vermeulen A., Verdonck L., and Kaufman K.M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84 (1999) 3666-3672
52. Wang C., Chan V., and Yeung R.T. The effect of heroin addiction on pituitary-testicular function. Clin Endocrinol 9 (1978) 455-461
53. Woody G., McLellan A.T., O'Brien C., Persky H., Stevens G., Arndt I., and Carroff S. Hormone secretion in methadone-dependent and abstinent patients. NIDA Res Monograph 81 (1988) 216-223
54. Zis A., Haskett R., Albala A., and Carroll B. Morphine inhibits cortisol and stimulates prolactin secretion in man. Psychoneuroendocrinology 9 (1984) 423-427